Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Ipsen S.A. ADR (IPSEY)

Ipsen S.A. ADR (IPSEY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Onivyde® Regimen Demonstrated Statistically Significant Improvement in Overall Survival in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma

Regulatory News:

OTC.VN : 0.405 (-1.22%)
IPN : 34.71 (-0.54%)
IPSEY : 28.0600 (+0.47%)
Ipsen Delivers Strong Sales Growth in the First Nine Months of 2022 and Confirms Its Full-year Guidance

Regulatory News:

OTC.VN : 0.405 (-1.22%)
IPN : 34.71 (-0.54%)
IPSEY : 28.0600 (+0.47%)
Ipsen Statement on Updated Timeline for Palovarotene FDA Advisory Committee Meeting

Regulatory News:

OTC.VN : 0.405 (-1.22%)
IPN : 34.71 (-0.54%)
IPSEY : 28.0600 (+0.47%)
Ipsen Completes Acquisition of Epizyme Expanding Its Portfolio in Oncology

Regulatory News:

OTC.VN : 0.405 (-1.22%)
IPN : 34.71 (-0.54%)
IPSEY : 28.0600 (+0.47%)
Epizyme (EPZM) Q2 Earnings Beat Estimates, Revenues Up Y/Y

Epizyme (EPZM) posts a narrower-than-expected loss in the second quarter. Revenues beat estimates.

NVAX : 17.61 (+6.60%)
EPZM : 1.4700 (-1.34%)
IPSEY : 28.0600 (+0.47%)
SESN : 0.5400 (+0.19%)
Ipsen Extends Expiration Date of Tender Offer for Epizyme, Inc. to 11 August 2022

Regulatory News:

OTC.VN : 0.405 (-1.22%)
EPZM : 1.4700 (-1.34%)
IPN : 34.71 (-0.54%)
IPSEY : 28.0600 (+0.47%)
Ipsen Announces Results from Phase III RESILIENT Trial Evaluating Onivyde® in Second-Line Monotherapy for Small Cell Lung Cancer

Regulatory News:

OTC.VN : 0.405 (-1.22%)
IPN : 34.71 (-0.54%)
IPSEY : 28.0600 (+0.47%)
Ipsen and Marengo Therapeutics Announce Strategic Partnership to Advance Two Precision Immuno-Oncology Candidates From Marengo’s STAR Platform Into the Clinic

Regulatory News:

OTC.VN : 0.405 (-1.22%)
IPN : 34.71 (-0.54%)
IPSEY : 28.0600 (+0.47%)
Ipsen Delivers Strong H1 2022 Results and Upgrades Its Full-Year Guidance

Regulatory News:

OTC.VN : 0.405 (-1.22%)
IPN : 34.71 (-0.54%)
IPSEY : 28.0600 (+0.47%)
EPIZYME INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Epizyme, Inc. - EPZM

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Epizyme, Inc. (NasdaqGS: EPZM) to Ipsen S.A....

EPZM : 1.4700 (-1.34%)
IPSEY : 28.0600 (+0.47%)

Barchart Exclusives

EPA Proposals Would Bring Major Changes to the U.S. Biofuel Efforts
Last Week’s Moves Corn 640-0 (-4.92%) | Soybeans 1438-6 (-1.41%) | SRW Wheat 737-2 (-5.06%) KC Wheat 846-6 (-5.28%) | Live Cattle 156.150 (+0.97%) | Lean Hogs 90.875 (+7.11%) _________________________________________________________________________________________ Welcome to your weekly agriculture report, where we cover everything you’ll need to know for the week ahead. This week,... Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar